Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Daunorubicin and Genistein

supplement:

Genistein

Research Papers that Mention the Interaction

Genistein acts synergistically with drugs such as tamoxifen, cisplatin, 1,3-bis 2-chloroethyl-1-nitrosourea (BCNU), dexamethasone, daunorubicin and tiazofurin, and with bioflavonoid food supplements such as quercetin, green-tea catechins and black-tea thearubigins.
Advances in experimental medicine and biology  •  2004  |  View Paper
However, we found that exposure to 200 microM genistein elicited an elevation in intracellular accumulation of rhodamine 123 (R123) and daunorubicin (DNR) in Pgp-expressing cell lines.
Biochemical pharmacology  •  1997  |  View Paper
Biochanin-A, genistein , quercetin, chalcone, silymarin, phloretin, morin, and kaempferol, at 100 microM concentrations, all significantly increased the accumulation of both DNM and VBL in Panc-1 cells, with morin increasing DNM and VBL accumulation by 546 +/- 50% (mean +/- SE, n = 9) and 553 +/- 37% (n = 9), respectively.
Journal of pharmaceutical sciences  •  2003  |  View Paper
In the majority of samples PSC 833 (19/26), CsA (22/26) and Vp (15/18) sensitized the cells to DNR whereas genistein made 25 out of 26 samples more resistant to DNR.
Leukemia  •  1998  |  View Paper
Thus, although the combination of DNR with genistein appeared to be as sensitive as the combination of calcein-AM with VCR, the former may be used to probe specific MRP activity whereas the latter provides a combined (P-gp + MRP) functional MDR parameter.
British Journal of Cancer  •  1995  |  View Paper
Genistein , verapamil, cyclosporin A and oua‐bain were also each able to modify, to some extent, accumulation of daunorubicin , whilst having essentially no effect on calcein accumulation.
International journal of cancer  •  1995  |  View Paper
The active transport of DNR in GLC4/ADR cells appeared to be a saturable process with an apparent Km of DNR of 1.4 +/- 0.4 microM. Genistein increased the apparent Km value of DNR , suggesting that this agent is a competitive inhibitor of DNR transport.
The purpose of this work was 2-fold: (i) to investigate the mechanism by which genistein inhibits the DNR efflux in the GLC4/ADR cells; and (ii) to characterize the dependence of DNR transport on ATP concentration in intact GLC4/ADR cells.
Biochemical pharmacology  •  1994  |  View Paper
Genistein inhibited the enhanced DNR efflux in the GLC4/ADR cells.
British Journal of Cancer  •  1993  |  View Paper
Consistent with broad substrate specificity, the drug glutathione conjugate APA-SG, oxidized glutathione, the LTD4 antagonist MK571, arsenate, and genistein were competitive inhibitors of daunorubicin transport, with Ki values of 32 microM, 25 microM, 1.9 microM, 108 microM, and 23 microM, respectively.
Biochemistry  •  1996  |  View Paper